Nofetumomab merpentan

WikiDoc Resources for Nofetumomab merpentan
Articles
Most recent articles on Nofetumomab merpentan Most cited articles on Nofetumomab merpentan Review articles on Nofetumomab merpentan Articles on Nofetumomab merpentan in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nofetumomab merpentan Images of Nofetumomab merpentan Photos of Nofetumomab merpentan Podcasts & MP3s on Nofetumomab merpentan Videos on Nofetumomab merpentan
Evidence Based Medicine
Cochrane Collaboration on Nofetumomab merpentan Bandolier on Nofetumomab merpentan TRIP on Nofetumomab merpentan
Clinical Trials
Ongoing Trials on Nofetumomab merpentan at Clinical Trials.gov Trial results on Nofetumomab merpentan Clinical Trials on Nofetumomab merpentan at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nofetumomab merpentan NICE Guidance on Nofetumomab merpentan NHS PRODIGY Guidance FDA on Nofetumomab merpentan CDC on Nofetumomab merpentan
Books
Books on Nofetumomab merpentan
News
Nofetumomab merpentan in the news Be alerted to news on Nofetumomab merpentan News trends on Nofetumomab merpentan
Commentary
Blogs on Nofetumomab merpentan
Definitions
Definitions of Nofetumomab merpentan
Patient Resources / Community
Patient resources on Nofetumomab merpentan Discussion groups on Nofetumomab merpentan Patient Handouts on Nofetumomab merpentan Directions to Hospitals Treating Nofetumomab merpentan Risk calculators and risk factors for Nofetumomab merpentan
Healthcare Provider Resources
Symptoms of Nofetumomab merpentan Causes & Risk Factors for Nofetumomab merpentan Diagnostic studies for Nofetumomab merpentan Treatment of Nofetumomab merpentan
Continuing Medical Education (CME)
CME Programs on Nofetumomab merpentan
International
Nofetumomab merpentan en Espanol Nofetumomab merpentan en Francais
Business
Nofetumomab merpentan in the Marketplace Patents on Nofetumomab merpentan
Experimental / Informatics
List of terms related to Nofetumomab merpentan

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Nofetumomab merpentan is a mouse monoclonal antibody and which it it used to treat cancer. Nofetumomab has it's chelator, merpentan. It also has a radioisotope, technetium-99m Tc.